Who Owns IHE?

iShares U.S. Pharmaceuticals ETF — Institutional Ownership & 13F Holdings

$86.52

+0.49 (+0.58%)

Market Cap

$686.3M

Shares Outstanding

7,753,168

Institutional Holders

152

Total Inst. Value

$481.2M

% of Float Held

QoQ Holder Change

+50

Institutional data as of Q1 2025

New Positions

32

Closed Positions

21

Increased

28

Decreased

43

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Fisher Asset Management, LLC$221.8M3,142,949
2NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO$158.2M2,242
3MORGAN STANLEY$15.0M211,984
4BANK OF AMERICA CORP /DE/$9.9M140,830
5GOLDMAN SACHS GROUP INC$7.4M104,815
6ROYAL BANK OF CANADA$7.2M101,984
7BROWN ADVISORY INC$6.4M91,067
8WELLS FARGO & COMPANY/MN$4.6M65,025
9RAYMOND JAMES FINANCIAL INC$4.3M61,609
10SUSQUEHANNA INTERNATIONAL GROUP, LLP$3.4M48,083

Biggest Buyers & Sellers This Quarter

Related Stocks

Frequently Asked Questions

How many institutional investors hold IHE?

As of Q1 2025, 152 institutional investors report holding IHE (iShares U.S. Pharmaceuticals ETF) in their 13F filings.

Which hedge fund owns the most IHE?

The largest institutional holder of IHE is Fisher Asset Management, LLC with $221.8M in shares.

Are institutions buying or selling IHE?

This quarter, 32 institutions opened new positions in IHE and 21 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.